Allophenic mice (obtained by aggregation of blastomeres from two embryos) have been produced from high- and low-tumor inbred strains to clarify, within the framework of the intact organism, the nature of gene control of susceptibility to specific neoplastic diseases. Some animals contain cells from a strain of high mammary tumor susceptibility (C3Hf) along with cells from a low-susceptibility strain (C57BL/6). The genotypic composition of their mammary epithelium was analyzed in normal glands, hyperplastic nodules, and one mammary adenocarcinoma, by transplantation of tissue from individual glands to respective pure-strain recipients, which differ allelically at the H-2 locus. In the normal glands, cells of both strains were detected by selective rejection of the antigenically incompatible cells in each host and acceptance of the histocompatible ones. The epithelium of a single gland must therefore originate from at least two clones. Single hyperplastic nodules also contained cells of both the high- and low-tumor strains. Graft outgrowths from such nodules, however, clearly exhibited strain-specific growth patterns: C3Hf cells grew as hyperplastic and C57 cells as normal in the corresponding hosts. These developmental differences (together with other mammary tumor data supplementing the one all-C3Hf tumor found here) suggest that the genetically mosaic, overtly hyperplastic nodules in situ had been covertly a mixture of C3Hf premalignant and C57 normal cells. Possession of characteristic nodular morphology, despite inclusion of normal along with hyperplastic cells, implies that nodules in single-genotype animals may also be phenotypically a mosaic of hyperplastic and normal cells. In genotypically mosaic nodules, retention of characteristic proliferative capacities by each cell strain after grafting, despite prolonged close association and exposure to common systemic influences in the allophenic animal, points to the mammary cells themselves as the chief focus of expression of specific genetic factors that control mammary tumor susceptibility.